Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A chair on alternatives?

Horst Spielmann1

  • 1National Centre for Documentation and Evaluation of Alternative Methods to Animal Experiments (ZEBET) at the Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV), D-Berlin, Germany. spielmann.zebet@bgvv.de

ALTEX
|July 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

60 Years of the 3Rs symposium: Lessons learned and the road ahead.

ALTEX·2024
Same author

In vitro tests to evaluate embryotoxicity and irritation of Chinese herbal medicine (Pentaherbs formulation) for atopic dermatitis.

Journal of ethnopharmacology·2023
Same author

The Current Status and Work of Three Rs Centres and Platforms in Europe.

Alternatives to laboratory animals : ATLA·2022
Same author

Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity.

Current research in toxicology·2022
Same author

The Rise of Three Rs Centres and Platforms in Europe.

Alternatives to laboratory animals : ATLA·2022
Same author

Open letter: Selection of a new Executive Director of the European Chemicals Agency (ECHA) provides an opportunity for the EU to lead in the field of chemicals management and implementation of innovative science.

ALTEX·2021
Same journal

New approach methodologies as first tier in an integrated approach to testing and assessment for non-genotoxic carcinogens.

ALTEX·2026
Same journal

Assessing the FDA's Year One Progress Report on Reducing Animal Testing.

ALTEX·2026
Same journal

Europe's roadmap finally arrives: Long on rigor, short on a clock.

ALTEX·2026
Same journal

Towards advanced in vitro models of testicular steroidogenesis for endocrine disruption testing.

ALTEX·2026
Same journal

Evaluation of EndoSens: A reliable skin sensitization assessment model.

ALTEX·2026
Same journal

Serum-free in vitro assessment of receptor-mediated endocrine activity including Phase-1 metabolism.

ALTEX·2026
See all related articles

European Union Directive 86/609/EEC guides experimental animal use. Germany saw a decrease, then an increase due to transgenic models, highlighting the need for in vitro tests and better education on the 3Rs concept.

Area of Science:

  • * Regulatory toxicology and animal welfare science.
  • * European Union chemicals policy and safety testing.

Background:

  • * Overview of the European Union (EU) legal framework for experimental animal use (Directive 86/609/EEC).
  • * Implementation activities by EU member states in regulatory animal testing.
  • * Trends in experimental animal use in Germany, including the impact of transgenic models.

Purpose of the Study:

  • * To review the legal framework and implementation of EU Directive 86/609/EEC.
  • * To discuss the role of international harmonization and data acceptance in chemical safety.
  • * To address educational deficits in animal experimentation and the 3Rs concept in Germany.

Main Methods:

  • * Review of EU legislation and member state activities.

Related Experiment Videos

  • * Analysis of trends in experimental animal use in Germany.
  • * Discussion of regulatory requirements for toxicity testing and the 3Rs concept.

    • Main Results:

    • * Significant decrease in experimental animals in Germany, followed by an increase due to transgenic models.
    • * Emphasis on international harmonization of test guidelines and mutual acceptance of data for chemical safety.
    • * EU White Paper calls for increased validation and acceptance of in vitro toxicity tests.

    Conclusions:

    • * Urgent need for new university chairs in Europe focusing on humane animal use (3Rs) and developing alternative toxicity tests.
    • * Establishment of validation centers for new toxicity tests under the EU chemicals policy.
    • * Importance of educating young scientists in biomedical sciences on the 3Rs concept and alternative methods.